[Clinical evaluation of bone marrow fibrosis in non-Hodgkin's lymphomas].
A study was performed in 62 patients with non-Hodgkin's lymphoma (ATL included) who were hospitalized between 1985 and 1991 and who underwent bone marrow aspiration and biopsy before or after treatment or at the time of recurrence. The relationships between the extent of bone marrow fibrosis and other prognostic factors as well as the effects of chemotherapy and bone marrow fibrositic prognosis were examined. The results were as follows: 1) The periods of survival in patients with high degree of fibrosis in bone marrow were significantly shortened. 2) The extent of bone marrow fibrosis significantly correlated with the presence or general symptoms, bone marrow invasion, and blood levels of LDH and Ca on blood biochemical examinations. 3) Effective therapy reduced collagen fibers as well as reticulin fibers in bone marrow. 4) Sixty-four percent of relapsing cases showed increase of bone marrow fibrosis. These results suggest that understanding the state of bone marrow fibrosis over the clinical course may give a good guide of indication the prognosis of malignant lymphoma.
Ishibashi
M
M
First Department of Internal Medicine, School of Medicine, Fukuoka University.
Hisano
S
S
Kimura
N
N
Morioka
E
E
Suzumiya
J
J
Kawara
T
T
Nakashima
H
H
Uchida
T
T
Okumura
M
M
Kikuchi
M
M
D001853:Bone Marrow / Q000473:pathology*; D005260:Female; D005355:Fibrosis; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D015996:Survival Rate